Genetic testing for rare heart conditions might someday expand to more common cardiac ailments. Already there are signs testing is dramatically changing how some conditions are treated and doctors' definition of who a patient is. Stephen Strauss reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Paynter, N.P. et al. J. Am. Med. Assoc. 303, 631–637 (2010).
Couzin-Frankel, J. Sci. 328, 1220–1221 (2010).
Wade, N. The New York Times, 12 June 2010 <http://www.nytimes.com/2010/06/13/health/research/13genome.html?_r=1&ref=general&src=me&pagewanted=all>
Marcus, F.I. et al. Circulation 121, 1533–1541 (2010).
Hodgkinson, K. et al. Genet. Med. 11, 859–865 (2009).
Schwartz, P.J. J. Am. Coll. Cardiol. 55, 2577–2579 (2010).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strauss, S. At the heart of genetic testing. Nat Biotechnol 28, 1003–1005 (2010). https://doi.org/10.1038/nbt1010-1003
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1010-1003